Clinical trials
Phase 3 Hematologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2006 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 9 |
| 2022 | 9 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Active, not recruiting | 13 |
| Terminated | 8 |
| Recruiting | 7 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| Loxo Oncology, Inc. | 5 |
| Vertex Pharmaceuticals Incorporated | 4 |
| BioMarin Pharmaceutical | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Agios Pharmaceuticals, Inc. | 2 |
| CTI BioPharma | 2 |
| Genzyme, a Sanofi Company | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 52 |
| Hemorrhagic Disorders | 12 |
| Anemia, Sickle Cell | 11 |
| Genetic Diseases, Inborn | 10 |
| Anemia | 8 |
| Blood Coagulation Disorders | 8 |
| Hemophilia A | 8 |
| Bone Marrow Diseases | 7 |
| Coagulation Protein Disorders | 7 |
| Blood Coagulation Disorders, Inherited | 6 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.